BioVie to discuss Phase 2 Long Covid trial results in conference call

September 14, 2026 4:01 PM

BioVie Inc. (NASDAQ: BIVI) announced it will host a conference call and webcast on September 15, 2026, at 8:30 a.m ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found